Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Pacira Pharm Inc (PCRX)

Pacira Pharm Inc (PCRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 681,899
  • Shares Outstanding, K 46,546
  • Annual Sales, $ 674,980 K
  • Annual Income, $ 41,960 K
  • 60-Month Beta 0.84
  • Price/Sales 0.98
  • Price/Cash Flow 3.41
  • Price/Book 0.71
Trade PCRX with:

Options Overview Details

View History
  • Implied Volatility 39.76% ( -3.58%)
  • Historical Volatility 193.24%
  • IV Percentile 11%
  • IV Rank 14.34%
  • IV High 197.17% on 07/15/24
  • IV Low 13.41% on 09/20/23
  • Put/Call Vol Ratio 0.27
  • Today's Volume 108
  • Volume Avg (30-Day) 336
  • Put/Call OI Ratio 1.18
  • Today's Open Interest 13,222
  • Open Int (30-Day) 16,345

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/24
See More
  • Average Estimate 0.53
  • Number of Estimates 7
  • High Estimate 0.84
  • Low Estimate 0.46
  • Prior Year 0.52
  • Growth Rate Est. (year over year) +1.92%

Price Performance

See More
Period Period Low Period High Performance
1-Month
12.61 +18.24%
on 09/12/24
15.80 -5.63%
on 08/30/24
+0.93 (+6.65%)
since 08/19/24
3-Month
11.16 +33.55%
on 08/13/24
29.61 -49.65%
on 06/24/24
-13.28 (-47.11%)
since 06/18/24
52-Week
11.16 +33.55%
on 08/13/24
35.95 -58.53%
on 01/08/24
-18.52 (-55.40%)
since 09/19/23

Most Recent Stories

More News
Pacira: Q2 Earnings Snapshot

Pacira: Q2 Earnings Snapshot

PCRX : 14.96 (+2.12%)
Pacira: Q1 Earnings Snapshot

Pacira: Q1 Earnings Snapshot

PCRX : 14.96 (+2.12%)
Pacira: Q4 Earnings Snapshot

Pacira: Q4 Earnings Snapshot

PCRX : 14.96 (+2.12%)
Pacira: Q3 Earnings Snapshot

Pacira: Q3 Earnings Snapshot

PCRX : 14.96 (+2.12%)
Pacira: Q2 Earnings Snapshot

Pacira: Q2 Earnings Snapshot

PCRX : 14.96 (+2.12%)
Pacira: Q1 Earnings Snapshot

Pacira: Q1 Earnings Snapshot

PCRX : 14.96 (+2.12%)
Pacira: Q4 Earnings Snapshot

Pacira: Q4 Earnings Snapshot

PCRX : 14.96 (+2.12%)
Pacira: Q3 Earnings Snapshot

Pacira: Q3 Earnings Snapshot

PCRX : 14.96 (+2.12%)
Pacira BioSciences Reports Preliminary Net Product Sales of $50.2 Million for July 2022

-- EXPAREL average daily sales for July 2022 were 105 percent of July 2021 -- TAMPA, Fla., Aug. 10, 2022 (GLOBE NEWSWIRE) -- Pacira BioSciences,...

PCRX : 14.96 (+2.12%)
NFL Alumni Association and Pacira BioSciences Team Up to Educate Athletes and Communities About Non-Opioid Options to Manage Pain

-- Multi-year initiative will leverage NFL Alumni events and educational opportunities to raise awareness about effective opioid alternatives --...

PCRX : 14.96 (+2.12%)

Business Summary

Pacira BioSciences, Inc. is a specialty pharmaceutical company focused on the development, commercialization and manufacture of proprietary pharmaceutical products primarily for use in hospitals and ambulatory surgery centers. These products are developed using the company's proprietary DepoFoam drug...

See More

Key Turning Points

3rd Resistance Point 16.32
2nd Resistance Point 15.77
1st Resistance Point 15.21
Last Price 14.96
1st Support Level 14.10
2nd Support Level 13.55
3rd Support Level 12.99

See More

52-Week High 35.95
Fibonacci 61.8% 26.48
Fibonacci 50% 23.56
Fibonacci 38.2% 20.63
Last Price 14.96
52-Week Low 11.16

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar